Medicament and method for reducing alcohol and/or tobacco consumption
Details for Australian Patent Application No. 2003253327 (hide)
International Classifications
Event Publications
30 October 2003 Complete Application Filed
Priority application(s): 102 35 556.8 03.08.02 DE
8 April 2004 Application Open to Public Inspection
Published as AU-B-2003253327
8 October 2009 Application Accepted
Published as AU-B-2003253327
29 October 2009 Section 223 Application Allowed
HF Arzneimittelforschung GmbH The time in which to pay an exam response fee has been extended to 30 Oct 2009. Address for service in Australia - Hodgkinson McInnes Patents Level 21, 201 Elizabeth Street Sydney NSW 2000
29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2E(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
24 December 2009 Corrigenda
Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2003 Delete all reference to Application No. 2003253327
4 February 2010 Standard Patent Sealed
17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003253326-METHOD FOR THE PRODUCTION OF PHENYLALANINE DERIVATIVES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser